HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Preparing for chaos: Hem/onc response crucial to radiation exposure incident
-
- Should preparation for a nuclear or natural disaster be part of physician residency?
- New prostate cancer endpoints, the FDA and Don Quixote Derek Raghavan, MD, PhD, FACP, FRACP, FASCO
- A winding road: One advanced practice provider’s journey in drug development and clinical trials Mary Jo Pilat, PhD, MS, PA-C, CCRP
- Urgent action necessary to address opioid drug shortage Jai N. Patel, PharmD, BCOP, CPP
- Guidelines recommend augmented breast cancer screening for black women, others at elevated risk
- CAR T-cell therapy may be effective for colorectal cancer
- Testicular cancer survivors may be at increased risk for cardiovascular disease
- UCLA pilot project fulfills patient wishes to improve end-of-life experience
-
- St. Jude Children’s Research Hospital launches public repository of pediatric cancer genomics data
- Study of t(11;14) translocation may offer ‘valuable real-world evidence’ to advance myeloma treatment
- Low-toxicity regimen may be best approach for mixed phenotype acute leukemia
- Liquid biopsy technique may detect brain tumor biomarkers
- Variables may help differentiate malignant, benign lung nodules
- Hypophysitis incidence high after ipilimumab therapy for melanoma
- Cancer survivors at increased risk for endocrine diseases
- Many US adults unaware of cancer drug shortages
-
- Ovarian suppression improves 8-year breast cancer survival
- Substantial variation exists in surgeon acceptance of more limited breast cancer surgery
- Circulating tumor cells may predict radiotherapy benefit in early-stage breast cancer
- Women with dense breasts have higher odds of screen-detected, interval breast cancers
- Frequent colorectal cancer follow-up does not improve recurrence, survival
- Radiotherapy with transarterial chemoembolization extends survival for certain patients with advanced hepatocellular carcinoma
- Addition of radiation to chemotherapy confers survival benefit for cervical cancer
- ACA leads to earlier detection of gynecologic cancers among young women
-
- Enzalutamide reduces risk for metastasis among men with castration-resistant prostate cancer
- Germline mutations common in advanced renal cell carcinoma
- Checkpoint inhibitors improve survival for metastatic melanoma with brain metastases
- Nivolumab shows antitumor activity in nasopharyngeal carcinoma
- HPV status of head, neck cancer influences fatigue, inflammation
- Depth of response predicts OS, PFS for non-small cell lung cancer
- Stereotactic radiosurgery alone improves survival for patients with brain metastases from small cell lung cancer
- MGMT promoter methylation prognostic biomarker for low-grade glioma
-
- Assessment, management tool alleviates cancer-related pain
- Experts highlight inconsistencies in guidelines on opioids for cancer pain
- Childhood cancer survivors show lack of concern over future health
- Splenectomy, splenic radiation linked to infection-related mortality among childhood cancer survivors
- ‘Simple’ model predicts risk for cancer-related venous thromboembolism
- Unrelated cord blood transplantation may be option for refractory severe aplastic anemia
- Plasma during air transport may benefit those at risk for hemorrhagic shock
- Denosumab noninferior to zoledronic acid for bone disease in myeloma
-
- Bone marrow transplant may extend survival in high-risk follicular lymphoma
- Leukemia disease burden impacts response with CAR T-cell therapy
- Researchers better characterize associations between melanoma, lymphoid neoplasms
- Breath analysis test shows strong accuracy for detecting esophagogastric cancer
- Hormone therapy increases diabetes risk among breast cancer survivors
- Anthracycline, gemcitabine moderately active in epithelioid sarcoma
- Risk stratification reduces exposure to radiation with ‘excellent OS’ for metastatic Wilms tumor
- Belief in fake causes of cancer appears widespread
-
- Flight attendants at increased risk for breast, skin cancers
- Stem cell source affects graft-versus-host disease occurrence for leukemia subtypes
- Chemoradiation improves survival for elderly patients with non-small cell lung cancer
- Mediterranean diet more effective than other diets at lowering prostate cancer risk
- FDA grants orphan drug designation to CLR 131 for Ewing sarcoma
- FDA expands Kisqali approval for advanced, metastatic breast cancer
- FDA approves Tibsovo for IDH1-mutated acute myeloid leukemia
- FDA expands Xtandi approval for prostate cancer
-
- FDA grants Tecentriq-Avastin combination breakthrough therapy designation for liver cancer
- FDA approves Nivestym, biosimilar to Neupogen, for treatment of neutropenia
- Pixuvri combination fails to prolong PFS in aggressive B-cell non-Hodgkin lymphoma
- Ninlaro maintenance therapy extends PFS in posttransplant myeloma
- Atezolizumab plus chemotherapy improves PFS, not OS, in non-small cell lung cancer
- Lenalidomide plus rituximab improves PFS for lymphoma
- First-line pembrolizumab improves survival for head, neck cancer
- Atezolizumab plus chemotherapy improves PFS for triple-negative breast cancer
-
- Luspatercept improves erythroid response in transfusion-dependent beta-thalassemia
- Phase 3 trial of ibrutinib plus R-CHOP for aggressive lymphoma subtype fails to meet primary endpoint
- Breast surgeon joins Atlantic Health System Cancer Care
- US Oncology Network appoints chief medical officer
- American Society for Radiation Oncology members receive fellow designation
- City of Hope appoints chief operating officer
- Pediatric hematologist among finalists for NIH foundation’s Trailblazer Prize
- American Society for Radiation Oncology elects officers
-
- Bonnie J. Addario Lung Cancer Foundation honors oncologist
- Fox Chase Cancer Center appoints assistant professor